Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Reporting season preview

Julia Lee
January 29, 2018

Market Update

Julia Lee
January 25, 2018

Market Update

Julia Lee
January 24, 2018

Market Update

Julia Lee
January 23, 2018

Market Update

Julia Lee
January 22, 2018

Market Update

Julia Lee
January 22, 2018

Market Update

Julia Lee
January 17, 2018

Your Money Your Call 16 January

Julia Lee
January 17, 2018

Market Update

Julia Lee
January 12, 2018

Market Update

Julia Lee
January 10, 2018